President Donald Trump said generic drug manufacturers will have two years to move production to the US or face a 100% import duty. Bloomberg's Mica Soellner reports on what could come next. -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9 Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more. Connec ...

THERE IS A BOOTH WHERE THERE IS A HUMANOID ROBOT AND THERE IS A HUMAN DRESSED IN EXACTLY THE SAME CLOTHING, TRADITIONAL KIND OF TIBETAN CLOTHING, AND I STOOD THERE FOR ABOUT 2.5% MINUTES BECAUSE I COULDN'T FIGURE OUT WHICH ONE WAS WHICH. HI, EVERYBODY, AND WELCOME TO HERE'S THE SCOOP FROM NBC NEWS. I'M YASMIN BASIN.SO WOULD I BE ABLE TO TELL THE DIFFERENCE BETWEEN A ROBOT AND A HUMAN. I DON'T KNOW. BUT JARED PERLO DID AFTER 2.5% MINUTES AND HE'S SHARING HIS EXPERIENCES WITH US AFTER HE VISITED AN AI CONFERE ...

Ping An has frozen new investments in US private markets over the past year, according to sources, a sign that unease following Donald Trump’s tariff assault has still not abated https://t.co/hSmoscX6rz ...

just when you think there's a quiet moment, tariffs are always going to come back into the picture. So, it was only a matter of time before this popped back up again. But the big underlying irritance is that Canada hasn't yet come to the table with the USMCA review talks.It's been entirely just the US and Mexico up until this point. Um, and so to my understanding, it seems like the US really wanted something to pressure Canada to concede some of the irritants, whether it be with um, some of the provinces st ...